FIELD: medicine.
SUBSTANCE: invention discloses application of vaccine composition, which contains prophylactically active anti-flu agent and adjuvant, representing compound PBS-96 of the following formula (III) 
or compound PBS-14 of the following formula (IV) 
for production of medication, intended for prevention or treatment of flu.
EFFECT: application of derivatives of galactosyl ceramides as adjuvants to anti-flu vaccine increases vaccine composition activity.
7 cl, 20 dwg, 3 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ENHANCING IMMUNE RESPONSE AND TARGET FOCUS BY ANTIGENS AND/OR DRUG | 2008 |
|
RU2548685C2 |
| COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSE TO ANTIGENS | 2008 |
|
RU2537188C2 |
| VACCINE COMPOSITION FOR USE IN IMMUNO-COMPROMISED POPULATIONS | 2013 |
|
RU2661408C2 |
| POLYVALENT VACCINE AGAINST INFLUENZA BASED ON NANOPARTICLES | 2019 |
|
RU2805552C2 |
| COMBINATION PREPARATION FOR INCREASING POTENCY OF VACCINE (VERSIONS) | 2008 |
|
RU2491090C2 |
| METHOD OF PRODUCING VACCINE ANTIGENS, OBTAINED VACCINE ANTIGENS AND USE THEREOF | 2015 |
|
RU2703147C2 |
| VACCINE COMPOSITION FOR NON-IMMUNISED INDIVIDUALS | 2013 |
|
RU2661407C2 |
| IMPROVED VACCINATION AGAINST INFLUENZA | 2013 |
|
RU2599496C2 |
| FLU VIRUS, CAPABLE OF INFECTING CANIDAE AND ITS APPLICATION | 2006 |
|
RU2520081C2 |
| INFLUENZA INFECTING DOGS AND USE THEREOF | 2014 |
|
RU2711807C2 |
